(RDN) Radian - Overview
Stock: Mortgage Insurance, Title Services, Real Estate Technology, Risk Management
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.01% |
| Yield on Cost 5y | 6.09% |
| Yield CAGR 5y | 16.96% |
| Payout Consistency | 91.9% |
| Payout Ratio | 24.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 24.5% |
| Relative Tail Risk | -0.49% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.13 |
| Alpha | -11.81 |
| Character TTM | |
|---|---|
| Beta | 0.608 |
| Beta Downside | 0.567 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.50% |
| CAGR/Max DD | 1.02 |
Description: RDN Radian January 08, 2026
Radian Group Inc. (NYSE:RDN) operates a diversified mortgage-and-real-estate services platform in the United States, providing private mortgage insurance, title and escrow services, appraisal management, and technology solutions to mortgage originators, lenders, investors, and GSEs. The firm originated as CMAC Investment Corp., rebranded in 1999, and is headquartered in Wayne, Pennsylvania.
Key operating metrics from the most recent 2023 filing show RDN generated $1.2 billion in gross written premium (GWP) for its mortgage-insurance business, with a combined ratio of 92 % and net income of $165 million, reflecting a modest profit margin in a rate-sensitive environment. The company’s earnings are closely tied to the U.S. housing market cycle; rising mortgage rates have compressed loan volumes but boosted insurance spreads, while the ongoing GSE reform agenda influences the demand for private mortgage insurance as banks seek alternative credit-risk solutions. Additionally, Radian’s proprietary “Radian Platform” SaaS offering has grown its recurring revenue base by roughly 15 % YoY, underscoring the sector trend toward digitization of underwriting and servicing workflows.
For a deeper quantitative view, the ValueRay platform provides a granular breakdown of RDN’s risk metrics and valuation levers.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 576.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.07 > 0.02 and ΔFCF/TA -5.25 > 1.0 |
| NWC/Revenue: -68.78% < 20% (prev 486.4%; Δ -555.2% < -1%) |
| CFO/TA -0.07 > 3% & CFO -556.5m > Net Income 576.1m |
| Net Debt (1.14b) to EBITDA (908.7m): 1.25 < 3 |
| Current Ratio: 0.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (137.9m) vs 12m ago -9.90% < -2% |
| Gross Margin: 92.11% > 18% (prev 0.95%; Δ 9116 % > 0.5%) |
| Asset Turnover: 15.19% > 50% (prev 15.28%; Δ -0.08% > 0%) |
| Interest Coverage Ratio: 9.53 > 6 (EBITDA TTM 908.7m / Interest Expense TTM 88.1m) |
Altman Z'' 3.39
| A: -0.11 (Total Current Assets 144.0m - Total Current Liabilities 1.01b) / Total Assets 8.20b |
| B: 0.61 (Retained Earnings 5.01b / Total Assets 8.20b) |
| C: 0.10 (EBIT TTM 839.3m / Avg Total Assets 8.31b) |
| D: 1.35 (Book Value of Equity 4.79b / Total Liabilities 3.55b) |
| Altman-Z'' Score: 3.39 = A |
Beneish M -0.19
| DSRI: 1.03 (Receivables 173.6m/172.5m, Revenue 1.26b/1.29b) |
| GMI: 1.03 (GM 92.11% / 94.92%) |
| AQI: 5.49 (AQ_t 0.98 / AQ_t-1 0.18) |
| SGI: 0.98 (Revenue 1.26b / 1.29b) |
| TATA: 0.14 (NI 576.1m - CFO -556.5m) / TA 8.20b) |
| Beneish M-Score: -0.19 (Cap -4..+1) = D |
What is the price of RDN shares?
Over the past week, the price has changed by +0.30%, over one month by -9.34%, over three months by -1.81% and over the past year by -1.98%.
Is RDN a buy, sell or hold?
- StrongBuy: 1
- Buy: 2
- Hold: 2
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the RDN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 39.3 | 19.5% |
| Analysts Target Price | 39.3 | 19.5% |
| ValueRay Target Price | 37.9 | 15.1% |
RDN Fundamental Data Overview January 26, 2026
P/E Forward = 7.5586
P/S = 3.4904
P/B = 0.9552
P/EG = 1.18
Revenue TTM = 1.26b USD
EBIT TTM = 839.3m USD
EBITDA TTM = 908.7m USD
Long Term Debt = 1.08b USD (from longTermDebt, last quarter)
Short Term Debt = 47.2m USD (from shortTermDebt, last quarter)
Debt = 1.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.14b USD (from netDebt column, last quarter)
Enterprise Value = 8.19m USD (4.44b + Debt 1.15b - CCE 5.59b)
Interest Coverage Ratio = 9.53 (Ebit TTM 839.3m / Interest Expense TTM 88.1m)
EV/FCF = -0.01x (Enterprise Value 8.19m / FCF TTM -560.2m)
FCF Yield = -6844 % (FCF TTM -560.2m / Enterprise Value 8.19m)
FCF Margin = -44.36% (FCF TTM -560.2m / Revenue TTM 1.26b)
Net Margin = 45.61% (Net Income TTM 576.1m / Revenue TTM 1.26b)
Gross Margin = 92.11% ((Revenue TTM 1.26b - Cost of Revenue TTM 99.6m) / Revenue TTM)
Gross Margin QoQ = 91.94% (prev 91.28%)
Tobins Q-Ratio = 0.00 (Enterprise Value 8.19m / Total Assets 8.20b)
Interest Expense / Debt = 1.49% (Interest Expense 17.2m / Debt 1.15b)
Taxrate = 23.10% (45.9m / 198.7m)
NOPAT = 645.5m (EBIT 839.3m * (1 - 23.10%))
Current Ratio = 0.14 (Total Current Assets 144.0m / Total Current Liabilities 1.01b)
Debt / Equity = 0.25 (Debt 1.15b / totalStockholderEquity, last quarter 4.65b)
Debt / EBITDA = 1.25 (Net Debt 1.14b / EBITDA 908.7m)
Debt / FCF = -2.03 (negative FCF - burning cash) (Net Debt 1.14b / FCF TTM -560.2m)
Total Stockholder Equity = 4.59b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.93% (Net Income 576.1m / Total Assets 8.20b)
RoE = 12.55% (Net Income TTM 576.1m / Total Stockholder Equity 4.59b)
RoCE = 14.80% (EBIT 839.3m / Capital Employed (Equity 4.59b + L.T.Debt 1.08b))
RoIC = 9.44% (NOPAT 645.5m / Invested Capital 6.84b)
WACC = 6.71% (E(4.44b)/V(5.60b) * Re(8.15%) + D(1.15b)/V(5.60b) * Rd(1.49%) * (1-Tc(0.23)))
Discount Rate = 8.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.34%
Fair Price DCF = unknown (Cash Flow -560.2m)
EPS Correlation: -54.46 | EPS CAGR: -48.98% | SUE: -4.0 | # QB: 0
Revenue Correlation: 33.20 | Revenue CAGR: -2.25% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.07 | Chg30d=-0.020 | Revisions Net=-2 | Analysts=6
EPS next Year (2026-12-31): EPS=4.45 | Chg30d=-0.007 | Revisions Net=-1 | Growth EPS=+4.2% | Growth Revenue=+5.7%